Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - TOTAL OTHER INCOME
Total Other Income TRVI - Trevi Therapeutics, Inc.
4.83 M
LAST VALUE
129.13%
2 YEAR CAGR
32.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR